Industry: Healthcare

Huawei, Intel among big firms selling patents in June-recorded transactions

Two deals could bring NPE risk but others stem from bankruptcies, buying and selling of business units and company product collaborations

05 July 2024

Historic moment as UPC hands down two full decisions within 24 hours of each other

The Unified Patent Court has handed patentees a win and a loss in its first on-the-merits rulings

04 July 2024

How new technologies are reshaping IP and deal terms in life sciences transactions

Each speciality comes with its own challenges and risks which shape how deals are negotiated and structured – and there is no ‘one-size fits all’ approach

26 June 2024

UPC grants Abbott a preliminary injunction – including for Ireland

But despite a couple of recent wins, PI applicants have a losing record at the Unified Patent Court

21 June 2024

Watershed moment as preliminary injunction granted in US biosimilar dispute

Regeneron’s PI against Samsung Bioepis in ongoing aflibercept litigation follows several failed attempts to obtain interim bans by biologic patentees

18 June 2024

Three crucial lessons to navigate IP and regulatory devils in medical innovation

Advice for biotech-pharma innovators to manage IP strategy while taking the risky gamble of introducing new drugs or medical devices to market

14 June 2024

Samsung’s ‘unclean hands’ dismissal victory was very rare

Docket Navigator research shows unclean hands unenforceability is exceedingly uncommon – succeeding in just three other cases since 2008

03 June 2024

Bayer suffers big blow at UK Court of Appeal, clearing path for generic Xarelto launches

The German company remains involved in more than 70 proceedings across 20-plus European countries

28 May 2024

The patent buyer behind IPA Technologies’ $242 million verdict

Michael Zhang, a former WiLAN associate vice president, talks about the verdict against Microsoft, his approach to licensing, and more

23 May 2024

Docket Navigator and IAM Litigation Report Q1 2024

Featured in Docket Navigator and IAM Litigation Report

In this edition, our team puts the magnifying glass to Docket Navigator data on the Patent Trial and Appeal Board – case filing trends, institution success, IPR outcomes, and party and firm rankings

22 May 2024